Filing Flows › Sunshine Biopharma (SBFM) › Q2 2026 › vs Q2 2025
Sunshine Biopharma (SBFM) Q2 2026 vs Q2 2025 (year over year)
Sunshine Biopharma's revenue fell $147K (-2%) from $9.4M in Q2 2025 to $9.3M in Q2 2026.
Sunshine Biopharma, Q2 2026: revenue $9.3M (-2% year over year), operating margin -17.4%, net loss $1.6M, operating cash flow −$918K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $9.3M | $9.4M | −$147K | -2% |
| Other income, net | $49K | $75K | −$26K | -35% |
| Net loss | $1.6M | $1.8M | −$207K | -12% |
| Costs & expenses | $10.9M | $11.5M | −$588K | -5% |
| Operating costs | $10.9M | $11.5M | −$588K | -5% |
| Cost of revenue | $6.8M | $6.0M | $850K | +14% |
| Operating expenses | $4.0M | $5.5M | −$1.4M | -26% |
| Operating cash sources | $1.6M | $1.8M | −$207K | -12% |
| Depreciation & amortization | $78K | $72K | $6K | +8% |
| Working capital & other | $568K | $425K | $143K | +34% |
| Cash used in operations | $918K | $1.3M | −$355K | -28% |
| Net loss absorbed | $1.6M | $1.8M | −$207K | -12% |
Questions
How much did Sunshine Biopharma's revenue grow year over year in Q2 2026?
Sunshine Biopharma's revenue fell $147K (-2%) from $9.4M in Q2 2025 to $9.3M in Q2 2026.